Semaglutide is a once-weekly injectable treatment designed to support weight management and metabolic health. By mimicking the effects of GLP-1 (glucagon-like peptide-1), it regulates appetite, enhances insulin secretion, and improves blood sugar control. This powerful peptide also reduces systemic inflammation and slows gastric emptying, helping to curb cravings and promote satiety. Semaglutide’s ability to target metabolic pathways makes it a key therapeutic option for individuals aiming to lose weight, stabilize glucose levels, and support long-term metabolic wellness.
